Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Head Lice |
Lice; Lice Infestation |
Clinical Trial: Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
This study is no longer recruiting patients.
|
Purpose
The purpose of this trial is to study the clinical effects of increasing the weekly fraction number for locally advanced head and neck cancers by a multi-institutional prospective randomised trial. The primary endpoint is to clarify whether a six fraction per week protocol has a greater effect on the survival, as compared to the conventional five fraction per week protocol.
| Condition | Intervention | Phase |
|---|---|---|
| Head and Neck Cancer | Procedure: Accelerated Radiotherapy Fractionation | Phase III |
MedlinePlus related topics: Head and Neck Cancer
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment
Official Title: Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Head and Neck Cancer
Exclusion Criteria:
- Unable to give an informed consent
Location Information
Study chairs or principal investigators
Bhadrasain Vikram, M.D., Study Director, International Atomic Energy Agency (IAEA)
More Information
Study ID Numbers: E33018
Last Updated: July 25, 2005
Record first received: July 15, 2005
ClinicalTrials.gov Identifier: NCT00120211
Health Authority: United Nations: International Atomic Energy Agency
ClinicalTrials.gov processed this record on 2005-08-02
Last Updated: July 25, 2005
Record first received: July 15, 2005
ClinicalTrials.gov Identifier: NCT00120211
Health Authority: United Nations: International Atomic Energy Agency
ClinicalTrials.gov processed this record on 2005-08-02
email this page
print this page
bookmark this page
feedback on this page
